AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
PlumBot: publish from draft
Line 67:
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings and organictop line growth by line <sup>p. 6</sup>
! style="text-align:left" | MetricEUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-sm" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings
| class="col-s" style="text-align:right" | EUR 8.1bn1
| class="col-s" style="text-align:right" | EUR 8.4bn4
| class="col-s" style="text-align:right" | +6% overall, +9% excluding AXA IM
|-
| style="text-align:left" | TopP&C top line growth
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +65%
|-
| style="text-align:left" | P&CLife top line growth
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +59%
|-
| style="text-align:left" | LifeHealth top line growth
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +95%
|-
| style="text-align:left" | Health
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +5%
|}
</div>
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
* '''Scaling the business''': Continued investments in growth and technology <sup>p. 6</sup>
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>.
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 105 ⟶ 104:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 gross written premium split (excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 125 ⟶ 124:
|}
</div>
* '''Secular trends fueling demand across businesses''': <sup>p. 7</sup>
** Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) <sup>p. 7</sup>
*** Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) <sup>p. 7</sup>
* '''Our right to win''': <sup>p. 7</sup>
** Leading brand & high customer NPS <sup>p. 7</sup>
** Strong and diversified distribution <sup>p. 7</sup>
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
* Pie chart represents FY25 gross written premium split excluding AXA IM and holdings <sup>p. 7</sup>.
 
=== Laying the foundation for the next plan ===
Line 142 ⟶ 150:
=== Strong delivery across our businesses ===
 
<div style="overflow-x:auto">
* '''France''' (27% of total GWP¹): <sup>p. 10</sup>
{| class="wikitable"
** '''Gross written premiums''' +6% to EUR 31bn <sup>p. 10</sup>
**|+ '''Underlying earnings''' +7%Performance toby EURgeography, 2.2bnFY25 <sup>p. 10</sup>
! style="text-align:left" | Region
* '''Europe''' (38% of total GWP¹): <sup>p. 10</sup>
! class="col-m" style="text-align:right" | % of total GWP
** '''Gross written premiums''' +6% to EUR 43bn <sup>p. 10</sup>
! class="col-m" style="text-align:right" | Gross written premiums (EUR billion)
** '''Underlying earnings''' +9% to EUR 3.5bn <sup>p. 10</sup>
! class="col-m" style="text-align:right" | Underlying earnings (EUR billion)
* '''AXA XL''' (17% of total GWP¹): <sup>p. 10</sup>
|-
** '''Gross written premiums''' +4% to EUR 19bn <sup>p. 10</sup>
| style="text-align:left" | France
** '''Underlying earnings''' +9% to EUR 1.9bn <sup>p. 10</sup>
| class="col-m" style="text-align:right" | 27%
* '''Asia, Africa & EME-LATAM''' (18% of total GWP¹): <sup>p. 10</sup>
| class="col-m" style="text-align:right" | 31 (+6%)
** '''Gross written premiums''' +13% to EUR 20bn <sup>p. 10</sup>
| class="col-m" style="text-align:right" | 2.2 (+7%)
** '''Underlying earnings''' +6% to EUR 1.5bn <sup>p. 10</sup>
|-
| style="text-align:left" | Europe
| class="col-m" style="text-align:right" | 38%
| class="col-m" style="text-align:right" | 43 (+6%)
| class="col-m" style="text-align:right" | 3.5 (+9%)
|-
| style="text-align:left" | AXA XL
| class="col-m" style="text-align:right" | 17%
| class="col-m" style="text-align:right" | 19 (+4%)
| class="col-m" style="text-align:right" | 1.9 (+9%)
|-
| style="text-align:left" | Asia, Africa & EME-LATAM
| class="col-m" style="text-align:right" | 18%
| class="col-m" style="text-align:right" | 20 (+13%)
| class="col-m" style="text-align:right" | 1.5 (+6%)
|}
</div>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 10</sup>.
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
Line 177 ⟶ 202:
=== L&H | Good momentum, well positioned to capture growth opportunities ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP breakdown by term <sup>p. 12</sup>
! style="text-align:left" | GWP EUR 57bn
! class="col-s" style="text-align:right" | —
|-
| style="text-align:left" | Short-term
| style="text-align:right" | 28%
|-
| style="text-align:left" | Long-term
| style="text-align:right" | 72%
|}
</div>
* '''Underlying earnings''' +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>
* (donut) '''GWP''' EUR 57bn <sup>p. 12</sup>
** '''Short-term''': 28% <sup>p. 12</sup>
** '''Long-term''': 72% <sup>p. 12</sup>
* (diagram) '''2025 Strategic Focus''' <sup>p. 12</sup>
** '''Long-term business''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
Line 191 ⟶ 226:
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
 
* '''FY25 Financial Performance''' <sup>p. 13</sup>
* Alban de Mailly Nesle <sup>p. 13</sup>
Line 217 ⟶ 251:
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
 
* (stacked bar) '''Combined ratio''' <sup>p. 15</sup>
** '''FY24 Total Combined Ratio''': 91.0% <sup>p. 15</sup>
*** Undiscounted CY loss ratio (ex Nat Cat): 67.4% <sup>p. 15</sup>
*** Expense ratio: 25.0% <sup>p. 15</sup>
*** Nat Cat: 3.8% <sup>p. 15</sup>
*** Prior year reserve development: -1.6% <sup>p. 15</sup>
*** Discount: -3.6% <sup>p. 15</sup>
** '''FY25 Total Combined Ratio''': 90.6% <sup>p. 15</sup>
*** Undiscounted CY loss ratio (ex Nat Cat): 67.0% <sup>p. 15</sup>
*** Expense ratio: 24.8% <sup>p. 15</sup>
*** Nat Cat: 3.4% <sup>p. 15</sup>
*** Prior year reserve development: -1.1% <sup>p. 15</sup>
*** Discount: -3.5% <sup>p. 15</sup>
* Better undiscounted current year loss ratio excluding Nat Cat from: <sup>p. 15</sup>
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Nat Cat charges below normalized load <sup>p. 15</sup>
* Lower reliance on prior year reserve development <sup>p. 15</sup>
* Taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
 
=== P&C | Earnings growth from higher underwriting and financial result ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ CombinedUnderlying ratioEarnings breakdownwaterfall <sup>p. 1516</sup>
! style="text-align:left" | ComponentEUR million
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)FY24
| style="text-align:right" | 67.4%5,510
| style="text-align:right" | 67.0%
| style="text-align:right" | —
|-
| style="text-align:left" | ExpenseVolume ratiogrowth
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%+292
| style="text-align:right" | —
|-
| style="text-align:left" | NatMargin Catimprovement
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%+189
| style="text-align:right" | —
|-
| style="text-align:left" | PriorInvestment year reserve developmentincome
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%+435
| style="text-align:right" | —
|-
| style="text-align:left" | DiscountInsurance finance expenses
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%235
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Combined Ratio'''Tax
| style="text-align:right" | '''91.0%'''
| style="text-align:right" | '''90.6%'''-169
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | —
| style="text-align:right" | -150
| style="text-align:right" | —
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 5,872
|}
</div>
 
=== P&C | Earnings growth from higher underwriting and financial result ===
 
* '''Underlying Earnings''' +9% (change at constant FX) <sup>p. 16</sup>
* (waterfall) '''Underlying Earnings''' FY24 to FY25:
** FY24: EUR 5,510m <sup>p. 16</sup>
** '''Volume growth''': +EUR 292m <sup>p. 16</sup>
** '''Margin improvement''': +EUR 189m <sup>p. 16</sup>
** '''Investment income''': +EUR 435m <sup>p. 16</sup>
** '''Insurance finance expenses''': -EUR 235m <sup>p. 16</sup>
** '''Tax''': -EUR 169m <sup>p. 16</sup>
** '''Affiliates, FX & other''': -EUR 150m <sup>p. 16</sup>
** FY25: EUR 5,872m <sup>p. 16</sup>
* '''Better underwriting result''' from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>
* '''Increase in investment income''' reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>
Line 298 ⟶ 360:
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
 
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes (change at constant scope and FX) <sup>p. 18</sup>
<div style="overflow-x:auto">
* (bar) '''PVEP''' -2% <sup>p. 18</sup>
{| class="wikitable"
|+** PVEPFY24 by segment, FY24Total: vsEUR FY2550.9bn <sup>p. 18</sup>
*** '''Protection & Health''': EUR 39.4bn <sup>p. 18</sup>
! style="text-align:left" | Segment
*** '''Unit-Linked''': EUR 8.5bn <sup>p. 18</sup>
! class="col-s" style="text-align:right" | FY24 Total
*** '''Capital-light G/A''': EUR 2.0bn <sup>p. 18</sup>
! class="col-s" style="text-align:right" | FY25 Total
*** '''Traditional G/A''': EUR 1.0bn <sup>p. 18</sup>
! class="col-s" style="text-align:right" | Change
** FY25 Total: EUR 49.4bn <sup>p. 18</sup>
|-
*** '''Protection & Health''': EUR 31.4bn (-4%) <sup>p. 18</sup>
| style="text-align:left; font-weight:bold" | Total
*** '''Unit-Linked''': EUR 8.5bn (+18%) <sup>p. 18</sup>
| class="col-s" style="text-align:right; font-weight:bold" | EUR 50.9bn
*** '''Capital-light G/A''': EUR 7.8bn (-10%) <sup>p. 18</sup>
| class="col-s" style="text-align:right; font-weight:bold" | EUR 49.4bn
*** '''Traditional G/A''': EUR 1.7bn (-10%) <sup>p. 18</sup>
| class="col-s" style="text-align:right; font-weight:bold" | -2%
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>
|-
* (bar) '''NB CSM''' (pre-tax) +3% <sup>p. 18</sup>
| style="text-align:left" | Protection & Health
** FY24: EUR 2.2bn <sup>p. 18</sup>
| class="col-s" style="text-align:right" | EUR 39.4bn
** FY25: EUR 2.2bn <sup>p. 18</sup>
| class="col-s" style="text-align:right" | EUR 31.4bn
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>
| class="col-s" style="text-align:right" | -4%
* (bar) '''NBV''' (post-tax) stable <sup>p. 18</sup>
|-
** FY24: EUR 2.3bn <sup>p. 18</sup>
| style="text-align:left" | Unit-Linked
** FY25: EUR 2.2bn <sup>p. 18</sup>
| class="col-s" style="text-align:right" | EUR 8.5bn
** '''NBV margin''': FY24 4.4%, FY25 4.5% <sup>p. 18</sup>
| class="col-s" style="text-align:right" | EUR 8.5bn
| class="col-s" style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A
| class="col-s" style="text-align:right" | EUR 2.0bn
| class="col-s" style="text-align:right" | EUR 7.8bn
| class="col-s" style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A
| class="col-s" style="text-align:right" | EUR 1.0bn
| class="col-s" style="text-align:right" | EUR 1.7bn
| class="col-s" style="text-align:right" | -10%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | Metric
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
| class="col-s" style="text-align:right" | EUR 2.3bn
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| class="col-s" style="text-align:right" | 4.4%
| class="col-s" style="text-align:right" | 4.5%
| class="col-s" style="text-align:right" | —
|}
</div>
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 378 ⟶ 402:
=== Life & Health | Strong momentum in both short-term and long-term business ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earnings waterfall <sup>p. 20</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | FY24
| style="text-align:right" | 3,323
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | —
| style="text-align:right" | +60
| style="text-align:right" | 479
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | —
| style="text-align:right" | +156
| style="text-align:right" | 2,804
|-
| style="text-align:left" | Financial result
| style="text-align:right" | —
| style="text-align:right" | -11
| style="text-align:right" | 946
|-
| style="text-align:left" | Tax, FX and others
| style="text-align:right" | —
| style="text-align:right" | -27
| style="text-align:right" | -728
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3,501
|}
</div>
* '''Underlying Earnings''' +7% (change at constant FX) <sup>p. 20</sup>
* (waterfall) '''Underlying Earnings''' FY24 to FY25:
** FY24: EUR 3,323m <sup>p. 20</sup>
** '''Short-term technical margin''': +EUR 60m <sup>p. 20</sup>
** '''Long-term result incl. CSM release''': +EUR 156m <sup>p. 20</sup>
** '''Financial result''': -EUR 11m <sup>p. 20</sup>
** '''Tax, FX and others''': -EUR 27m <sup>p. 20</sup>
** FY25: EUR 3,501m <sup>p. 20</sup>
*** '''Short-term technical margin''': EUR 479m <sup>p. 20</sup>
*** '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup>
*** '''Financial result''': EUR 946m <sup>p. 20</sup>
*** '''Tax & others''': -EUR 728m <sup>p. 20</sup>
* '''Strong short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>
* '''Higher long-term results''' from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>
Line 399 ⟶ 451:
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
 
<div style="overflow-x:auto">
* '''Underlying earnings''' (constant FX) +6% to EUR 8.4bn (FY25) from EUR 8.1bn (FY24) <sup>p. 21</sup>
{| class="wikitable fintable"
** '''Property & Casualty''': EUR 5.9bn (+9%) <sup>p. 21</sup>
**|+ '''LifeUnderlying &earnings Health''':and EURnet 3.5bnincome (+7%)by segment <sup>p. 21</sup>
! style="text-align:left" | EUR billion
** '''Asset Management''': EUR 0.2bn (-57%) <sup>p. 21</sup>
! class="col-s" style="text-align:right" | FY24
** '''Holdings & other''': EUR -1.2bn (stable) <sup>p. 21</sup>
! class="col-s" style="text-align:right" | FY25
* '''Net income''' (reported) +26% to EUR 9.8bn (FY25) from EUR 7.9bn (FY24) <sup>p. 21</sup>
! class="col-s" style="text-align:right" | Change
** '''Non-financial flows''': EUR +2.1bn (FY25) vs EUR -0.5bn (FY24) <sup>p. 21</sup>
|-
*** '''Capital gains from AXA IM disposal''': EUR +2.2bn (FY25) <sup>p. 21</sup>
| style="text-align:left" | '''Underlying earnings''' (constant FX)
** '''Financial flows''' (incl. RCG): EUR -0.7bn (FY25) vs EUR +0.3bn (FY24) <sup>p. 21</sup>
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Property & Casualty
| style="text-align:right" | —
| style="text-align:right" | 5.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | Life & Health
| style="text-align:right" | —
| style="text-align:right" | 3.5
| style="text-align:right" | +7%
|-
| style="text-align:left" | Asset Management
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | -57%
|-
| style="text-align:left" | Holdings & other
| style="text-align:right" | —
| style="text-align:right" | -1.2
| style="text-align:right" | stable
|-
| style="text-align:left" | '''Net income''' (reported)
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left" | Capital gains from AXA IM disposal
| style="text-align:right" | —
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|}
</div>
 
* (bar) '''Underlying earnings per share''': EUR 3.86 (FY25) vs EUR 3.59 (FY24), +8% <sup>p. 21</sup>
** +6% from earnings growth <sup>p. 21</sup>
Line 418 ⟶ 516:
* '''Financial flows''' lower, reflecting unfavorable forex impact <sup>p. 21</sup>
 
<div style="overflow-x:auto">
* '''Shareholders' equity''' (Group share) <sup>p. 22</sup>
{| class="wikitable fintable"
** '''SHE (excl. OCI)''': EUR 54.0bn (FY25) vs EUR 52.7bn (HY25) vs EUR 58.0bn (FY24) <sup>p. 22</sup>
**|+ Shareholders'''Net OCI''': EUR -6.8bn (FY25) vs EUR -7.2bn (HY25) vsequity EURand -8.1bnrelated (FY24)metrics <sup>p. 22</sup>
! style="text-align:left" | EUR billion
** '''SHE (excl. OCI & undated subordinated debt)''': EUR 49.4bn (FY25) vs EUR 47.0bn (HY25) vs EUR 53.2bn (FY24) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY24
** '''Debt gearing''': 22.3% (FY25) vs 23.4% (HY25) vs 20.6% (FY24) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | HY25
** '''Underlying ROE''': 16.0% (FY25) vs 17.5% (HY25) vs 15.2% (FY24) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY25
* '''Opening Shareholders' equity''': EUR 49.9bn (FY24 to FY25) and EUR 45.5bn (HY25 to FY25) <sup>p. 22</sup>
|-
* '''Change in Net OCI''': EUR 1.3bn (FY24 to FY25) and EUR 0.4bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | '''Shareholders' equity''' (Group share)
* '''Net income for the period''': EUR 9.8bn (FY24 to FY25) and EUR 5.9bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | —
* '''Dividend''': EUR -4.6bn (FY24 to FY25) <sup>p. 22</sup>
| style="text-align:right" | —
* '''Annual share buyback''': EUR -1.2bn (FY24 to FY25) <sup>p. 22</sup>
| style="text-align:right" | —
* '''Anti-dilutive share buyback following the sale of AXA IM''': EUR -3.5bn (FY24 to FY25) and EUR -3.5bn (HY25 to FY25) <sup>p. 22</sup>
|-
* '''Undated subordinated debt''' (including interest charges): EUR -0.3bn (FY24 to FY25) and EUR -1.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | SHE (excl. OCI)
* '''Forex''': EUR -3.5bn (FY24 to FY25) and EUR -0.1bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 58.0
* '''Other''': EUR -0.6bn (FY24 to FY25) and EUR 0.3bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 52.7
* '''Closing Shareholders' equity''': EUR 47.2bn (FY24 to FY25) and EUR 47.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | '''Debt gearing'''
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | '''Underlying ROE'''
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Reconciliation of Shareholders' Equity <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | '''Opening Shareholders' equity'''
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | 1.3
| style="text-align:right" | 0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | 9.8
| style="text-align:right" | 5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | —
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | —
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | 0.3
|-
| style="text-align:left" | '''Closing Shareholders' equity'''
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
 
== Higher organic cash remittance and robust cash position at Holding ==
Line 439 ⟶ 609:
=== Higher organic cash remittance and robust cash position at Holding ===
 
<div style="overflow-x:auto">
* (bar) '''Net Cash Remittance''': EUR 7.5bn (FY25) vs EUR 7.7bn (FY24) <sup>p. 23</sup>
{| class="wikitable fintable"
** FY24 breakdown: EUR 7.1bn (ordinary cash remittance) + EUR 0.6bn (proceeds related to in-force treaties²) <sup>p. 23</sup>
*|+ Cash '''Remittance ratio¹''': 82% (FY25) vsand 82%Cash (FY24)Position <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | '''Net Cash Remittance'''
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Remittance ratio
| style="text-align:right" | 82%
| style="text-align:right" | 82%
|}
</div>
 
* FY24 breakdown: EUR 7.1bn (ordinary cash remittance) + EUR 0.6bn (proceeds related to in-force treaties²) <sup>p. 23</sup>
* '''FY24 Cash position''': EUR 4.0bn <sup>p. 23</sup>
* '''Net cash remittance from subsidiaries''': +EUR 7.5bn <sup>p. 23</sup>
Line 458 ⟶ 643:
=== Solvency II at 224% ===
 
<div style="overflow-x:auto">
* (waterfall) '''Eligible Own Funds (EOF)''': EUR 56.4bn (FY25) vs EUR 55.9bn (FY24) <sup>p. 24</sup>
{| class="wikitable fintable"
** Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup>
*|+ (waterfall) '''Solvency Capital Requirement (SCR)''': EUR 25.2bn (FY25) vsII EURmetrics 25.9bnand (FY24)sensitivities <sup>p. 24</sup>
! style="text-align:left" | EUR billion
** Changes: EUR 0.0bn, +EUR 0.6bn, EUR 0.0bn, -EUR 1.2bn, EUR 0.0bn, -EUR 0.2bn <sup>p. 24</sup>
! class="col-s" style="text-align:right" | FY24
* (waterfall) '''Solvency II ratio''': 224% (FY25) vs 216% (FY24) <sup>p. 24</sup>
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | '''Eligible Own Funds (EOF)'''
| style="text-align:right" | 55.9
| style="text-align:right" | 56.4
|-
| style="text-align:left" | '''Solvency Capital Requirement (SCR)'''
| style="text-align:right" | 25.9
| style="text-align:right" | 25.2
|-
| style="text-align:left" | '''Solvency II ratio'''
| style="text-align:right" | 216%
| style="text-align:right" | 224%
|}
</div>
 
* Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup>
* Changes: EUR 0.0bn, +EUR 0.6bn, EUR 0.0bn, -EUR 1.2bn, EUR 0.0bn, -EUR 0.2bn <sup>p. 24</sup>
* '''Solvency II ratio''': 224% (FY25) vs 216% (FY24) <sup>p. 24</sup>
** '''Regulatory & model changes''': +0pts <sup>p. 24</sup>
** '''Normalized capital generation''': +28pts <sup>p. 24</sup>
Line 469 ⟶ 673:
** '''Dividend & annual share buyback''': -24pts <sup>p. 24</sup>
** '''Management actions, debt & other''': +2pts <sup>p. 24</sup>
 
* (bar) '''Key sensitivities''' on Ratio as of December 31, 2025 (224%) <sup>p. 24</sup>
<div style="overflow-x:auto">
** '''Interest rate +50bps''': +2 pts <sup>p. 24</sup>
{| class="wikitable fintable"
** '''Interest rate -50bps''': -1 pt <sup>p. 24</sup>
**|+ '''CorporateKey spreadssensitivities +50bps''':on Solvency II Ratio as of December 31, -12025 pt(224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
** '''Euro Sovereign spreads +50bps¹''': -7 pts <sup>p. 24</sup>
! class="col-s" style="text-align:right" | Impact (pts)
** '''Credit migration²''': -4 pts <sup>p. 24</sup>
|-
** '''Listed Equity (excl. PE & Infra) +25%''': -1 pt <sup>p. 24</sup>
| style="text-align:left" | Interest rate +50bps
** '''Listed Equity (excl. PE & Infra) -25%''': +2 pts <sup>p. 24</sup>
| style="text-align:right" | +2
** '''PE & Infra +25%''': +14 pts <sup>p. 24</sup>
|-
** '''PE & Infra -25%''': -19 pts <sup>p. 24</sup>
| style="text-align:left" | Interest rate -50bps
** '''Inflation swap curve +50bps''': -5 pts <sup>p. 24</sup>
| style="text-align:right" | -1
|-
| style="text-align:left" | Corporate spreads +50bps
| style="text-align:right" | -1
|-
| style="text-align:left" | Euro Sovereign spreads +50bps
| style="text-align:right" | -7
|-
| style="text-align:left" | Credit migration
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (excl. PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (excl. PE & Infra) -25%
| style="text-align:right" | +2
|-
| style="text-align:left" | PE & Infra +25%
| style="text-align:right" | +14
|-
| style="text-align:left" | PE & Infra -25%
| style="text-align:right" | -19
|-
| style="text-align:left" | Inflation swap curve +50bps
| style="text-align:right" | -5
|}
</div>
 
* ¹Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>.
* ²Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) <sup>p. 24</sup>.
Line 485 ⟶ 717:
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
 
<div style="overflow-x:auto">
* '''Ratio as of 31/12/2025''': 224% <sup>p. 25</sup>
{| class="wikitable fintable"
* '''Impact of the end of grandfathering period on January 1, 2026''': -10pts to 215% <sup>p. 25</sup>
**|+ EURSolvency 2.4bnII grandfatheredRatio debt no longer eligible as capital from January 1, 2026adjustments <sup>p. 25</sup>
! style="text-align:left" | Item
* '''Impact of Solvency II revision to come into effect in 1Q27''': +17pts¹ <sup>p. 25</sup>
! class="col-m" style="text-align:right" | Impact
** No change expected in organic capital generation <sup>p. 25</sup>
|-
** Additional capital flexibility <sup>p. 25</sup>
| style="text-align:left" | '''Ratio as of 31/12/2025'''
| style="text-align:right" | 224%
|-
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026
| style="text-align:right" | -10pts to 215%
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
| style="text-align:right" | +17pts
|}
</div>
 
* EUR 2.4bn grandfathered debt no longer eligible as capital from January 1, 2026 <sup>p. 25</sup>
* No change expected in organic capital generation <sup>p. 25</sup>
* Additional capital flexibility <sup>p. 25</sup>
* ¹Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
 
Line 586 ⟶ 832:
=== General Account invested assets ===
 
<div style="overflow-x:auto">
* (donut) '''FY25 Total General Account invested assets''': EUR 450bn <sup>p. 33</sup>
{| class="wikitable fintable"
** '''Fixed income''': 77% <sup>p. 33</sup>
**|+ '''RealFY25 estate''':Total 9%General Account invested assets <sup>p. 33</sup>
! style="text-align:left" | EUR billion
** '''Infrastructure equity''': 2% <sup>p. 33</sup>
! class="col-s" style="text-align:right" | %
** '''Listed equities''': 2% <sup>p. 33</sup>
|-
** '''Private equity and hedge funds''': 5% <sup>p. 33</sup>
| style="text-align:left" | '''Fixed income'''
** '''Cash''': 4% <sup>p. 33</sup>
| style="text-align:right" | 345
** '''Policy loans''': 0% <sup>p. 33</sup>
| style="text-align:right" | 77
* '''Invested assets''' (100%) in EUR bn (FY25):
|-
** '''Fixed income''': EUR 345bn (77%) <sup>p. 33</sup>
| style="text-align:left; padding-left:1.5em" | o/w Government bonds
*** o/w '''Government bonds''': EUR 167bn (37%) <sup>p. 33</sup>
| style="text-align:right" | 167
*** o/w '''Corporate bonds and loans''': EUR 121bn (27%) <sup>p. 33</sup>
| style="text-align:right" | 37
*** o/w '''Other fixed income'''¹: EUR 56bn (13%) <sup>p. 33</sup>
|-
** '''Real estate''': EUR 41bn (9%) <sup>p. 33</sup>
| style="text-align:left; padding-left:1.5em" | o/w Corporate bonds and loans
** '''Infrastructure equity''': EUR 10bn (2%) <sup>p. 33</sup>
| style="text-align:right" | 121
** '''Listed equities'''²: EUR 10bn (2%) <sup>p. 33</sup>
| style="text-align:right" | 27
** '''Private equity and hedge funds'''³: EUR 23bn (5%) <sup>p. 33</sup>
|-
** '''Cash''': EUR 19bn (4%) <sup>p. 33</sup>
| style="text-align:left; padding-left:1.5em" | o/w Other fixed income
** '''Policy loans''': EUR 2bn (0%) <sup>p. 33</sup>
| style="text-align:right" | 56
** '''Total Insurance Invested Assets'''⁴: EUR 450bn (100%) <sup>p. 33</sup>
| style="text-align:right" | 13
* '''Duration gap''': -0.4 year <sup>p. 33</sup>
|-
| style="text-align:left" | '''Real estate'''
| style="text-align:right" | 41
| style="text-align:right" | 9
|-
| style="text-align:left" | '''Infrastructure equity'''
| style="text-align:right" | 10
| style="text-align:right" | 2
|-
| style="text-align:left" | '''Listed equities'''
| style="text-align:right" | 10
| style="text-align:right" | 2
|-
| style="text-align:left" | '''Private equity and hedge funds'''
| style="text-align:right" | 23
| style="text-align:right" | 5
|-
| style="text-align:left" | '''Cash'''
| style="text-align:right" | 19
| style="text-align:right" | 4
|-
| style="text-align:left" | '''Policy loans'''
| style="text-align:right" | 2
| style="text-align:right" | 0
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | 450
| style="text-align:right" | 100
|}
</div>
* Duration gap: -0.4 year <sup>p. 33</sup>
* ¹ '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* ² '''Listed equities''' includes hedges; Listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
Line 614 ⟶ 891:
=== Structured and Private Credit assets ===
 
<div style="overflow-x:auto">
* '''Invested assets''' (100%) in EUR bn (FY25):
{| class="wikitable fintable"
** '''Residential Mortgages''': EUR 16bn (4% of G/A portfolio) <sup>p. 34</sup>
***|+ EURFY25 6bnInvested Dutchassets mortgages,by NHG guaranteedtype <sup>p. 34</sup>
! style="text-align:left" | EUR billion
*** EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>
**! '''CLOclass="col-s" & ABS'''style="text-align:right" EUR| 25bn (6% of G/A portfolio) <sup>p. 34</sup>
|-
*** 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 34</sup>
| style="text-align:left" | '''Residential Mortgages'''
** '''Infrastructure debt''': EUR 8bn (2% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:right" | 16
*** Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup>
| style="text-align:right" | 4
** '''CRE debt''': EUR 8bn (2% of G/A portfolio) <sup>p. 34</sup>
|-
*** Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>
| style="text-align:left" | EUR 6bn Dutch mortgages, NHG guaranteed
** '''Mid-Market lending''': EUR 10bn (2% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:right" | —
*** Strong diversification with EUR 8m average ticket <sup>p. 34</sup>
| style="text-align:right" | —
*** Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup>
|-
** '''Other''': EUR 2bn (0% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:left" | EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
** '''Total Structured and Private Credit Assets''': EUR 69bn (15% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:right" | —
*** o/w 54% participating <sup>p. 34</sup>
| style="text-align:right" | —
|-
| style="text-align:left" | '''CLO & ABS'''
| style="text-align:right" | 25
| style="text-align:right" | 6
|-
| style="text-align:left" | 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Infrastructure debt'''
| style="text-align:right" | 8
| style="text-align:right" | 2
|-
| style="text-align:left" | Skewed towards resilient industries (Telecom, Utilities, Transport)
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''CRE debt'''
| style="text-align:right" | 8
| style="text-align:right" | 2
|-
| style="text-align:left" | Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Mid-Market lending'''
| style="text-align:right" | 10
| style="text-align:right" | 2
|-
| style="text-align:left" | Strong diversification with EUR 8m average ticket
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Other'''
| style="text-align:right" | 2
| style="text-align:right" | 0
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | 69
| style="text-align:right" | 15
|-
| style="text-align:left; padding-left:1.5em" | o/w 54% participating
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
* G/A: General Account <sup>p. 34</sup>
 
=== Investment portfolio | Fixed Income reinvestment ===
 
<div style="overflow-x:auto">
* (donut) '''FY25 Fixed Income Reinvestment''': EUR 57bn <sup>p. 35</sup>
{| class="wikitable fintable"
** '''Government bonds & related'''¹: 32% (Average rating: AA) <sup>p. 35</sup>
**|+ '''InvestmentFY25 gradeFixed credit''':Income 40% (Average rating: A)Reinvestment <sup>p. 35</sup>
! style="text-align:left" | Category
** '''ABS/CLO/IG fund financing''': 21% <sup>p. 35</sup>
! class="col-s" style="text-align:right" | %
** '''Below investment grade credit''': 7% <sup>p. 35</sup>
! class="col-s" style="text-align:right" | Average rating
* (bar) '''FY25 Fixed Income Reinvestment Yield''':
|-
** '''Public fixed income'''¹: 3.5% <sup>p. 35</sup>
| style="text-align:left" | Government bonds & related
** '''Private & Structured fixed income'''²: 4.7% <sup>p. 35</sup>
| style="text-align:right" | 32
** '''Total fixed income''': 3.9% <sup>p. 35</sup>
| style="text-align:right" | AA
* '''Euro 57 billion fixed income invested at 3.9%''' <sup>p. 35</sup>
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40
| style="text-align:right" | A
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" | Category
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | 3.9%
|}
</div>
* Euro 57 billion fixed income invested at 3.9% <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
Line 650 ⟶ 1,010:
* ² '''Private & Structured fixed income''' refers to Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup>
 
<div style="overflow-x:auto">
* '''Table of contents''':
{| class="wikitable fintable"
** 1. Debt and Invested Assets, p.31 <sup>p. 36</sup>
**|+ 2.Table Additionalof P&C disclosures, p.36contents <sup>p. 36</sup>
! style="text-align:left" | Section
** 3. Additional IFRS17 disclosures, p.41 <sup>p. 36</sup>
! class="col-s" style="text-align:right" | Page
** 4. Sustainability, p.44 <sup>p. 36</sup>
|-
| style="text-align:left" | 1. Debt and Invested Assets
| style="text-align:right" | 31
|-
| style="text-align:left" | 2. Additional P&C disclosures
| style="text-align:right" | 36
|-
| style="text-align:left" | 3. Additional IFRS17 disclosures
| style="text-align:right" | 41
|-
| style="text-align:left" | 4. Sustainability
| style="text-align:right" | 44
|}
</div>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 763 ⟶ 1,137:
|}
</div>
* Technical reserves include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
Line 978 ⟶ 1,353:
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des Marchésmarchés Financiersfinanciers
* '''APAC''': Asia-Pacific
* '''AY''': Accident Year
* '''BBA''': BeneficialBearer Business AcquisitionBond
* '''CDP''': Carbon Disclosure Project
* '''CLO''': Collateralized Loan Obligation
* '''CRE''': Commercial Real Estate
* '''CSA''': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY''': CurrentCalendar Year
* '''DPS''': Dividend Per Share
* '''EME''': Emerging Markets
Line 994 ⟶ 1,370:
* '''ESMA''': European Securities and Markets Authority
* '''EU''': European Union
* '''EUR''': Euro
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
Line 1,012 ⟶ 1,389:
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
* '''PAA''': Premium Allocation Approach
Line 1,017 ⟶ 1,395:
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''RCG''': ReconciledReinsurance CashCost Generatedof Guarantees
* '''ROE''': Return On Equity
* '''SCR''': Solvency Capital Requirement
* '''SHE''': Shareholders' Equity
* '''SME''': Small and Medium-sized Enterprises
* '''TVOG''': Time Value of Options &and Guarantees
* '''UEPS''': Underlying Earnings Per Share
* '''UK''': United Kingdom